Cargando…

Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart

BACKGROUND: With chronic ischemia after myocardial infarction, the resulting scar tissue result in electrical and structural remodeling vulnerable to an arrhythmogenic substrate. The cholinergic anti‐inflammatory pathway elicited by vagal nerve via α7 nicotinic acetylcholine receptors (α7‐nAChR) can...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shu‐Jie, Li, Yue‐Chun, Shi, Zhe‐Wei, Lin, Zhong‐Hao, Rao, Zhi‐Heng, Tai, Si‐Chao, Chu, Mao‐Ping, Li, Lei, Lin, Jia‐Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634297/
https://www.ncbi.nlm.nih.gov/pubmed/28928157
http://dx.doi.org/10.1161/JAHA.117.006510
_version_ 1783270060618416128
author Wu, Shu‐Jie
Li, Yue‐Chun
Shi, Zhe‐Wei
Lin, Zhong‐Hao
Rao, Zhi‐Heng
Tai, Si‐Chao
Chu, Mao‐Ping
Li, Lei
Lin, Jia‐Feng
author_facet Wu, Shu‐Jie
Li, Yue‐Chun
Shi, Zhe‐Wei
Lin, Zhong‐Hao
Rao, Zhi‐Heng
Tai, Si‐Chao
Chu, Mao‐Ping
Li, Lei
Lin, Jia‐Feng
author_sort Wu, Shu‐Jie
collection PubMed
description BACKGROUND: With chronic ischemia after myocardial infarction, the resulting scar tissue result in electrical and structural remodeling vulnerable to an arrhythmogenic substrate. The cholinergic anti‐inflammatory pathway elicited by vagal nerve via α7 nicotinic acetylcholine receptors (α7‐nAChR) can modulate local and systemic inflammatory responses. Here, we aimed to clarify a novel mechanism for the antiarrhythmogenic properties of vagal nerve during the ischemic cardiomyopathy (ICM). METHODS AND RESULTS: Left anterior descending artery of adult male Sprague‐Dawley rats was ligated for 4 weeks to develop ICM. Western blot revealed that eliciting the cholinergic anti‐inflammatory pathway by nicotine treatment showed a significant reduction in the amounts of collagens, cytokines, and other inflammatory mediators in the left ventricular infarcted border zone via inhibited NF‐κB activation, whereas it increased the phosphorylated connexin 43. Vagotomy inhibited the anti‐inflammatory, anti‐fibrosis, and anti‐arrhythmogenic effect of nicotine administration. And immunohistochemistry confirmed that the nicotine administration‐induced increase of connexin 43 was located in intercellular junctions. Furthermore nicotine treatment suppressed NF‐κB activation in lipopolysaccharide‐stimulated RAW264.7 cells, and α‐bungarotoxin (an α7‐nAChR selective antagonist) partly inhibited the nicotine‐treatment effect. In addition, 4‐week nicotine administration slightly improved the cardiac function, increased cardiac parasympathetic tone, decreased the prolonged QTc, and decreased the arrhythmia score of programmed electric stimulation‐induced ventricular arrhythmia. CONCLUSIONS: Eliciting the cholinergic anti‐inflammatory pathway exerts anti‐arrhythmogenic effects against ICM‐induced ventricular arrhythmia accompanied by downregulation of cytokines, downgenerating of collagens, decrease in sympathetic/parasympathetic ratio, and prevention of the loss of phosphorylated connexin 43 during ICM. Our findings may suggest a promising therapy for the generation of ICM‐induced ventricular arrhythmia by eliciting the cholinergic anti‐inflammatory pathway.
format Online
Article
Text
id pubmed-5634297
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56342972017-10-18 Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart Wu, Shu‐Jie Li, Yue‐Chun Shi, Zhe‐Wei Lin, Zhong‐Hao Rao, Zhi‐Heng Tai, Si‐Chao Chu, Mao‐Ping Li, Lei Lin, Jia‐Feng J Am Heart Assoc Original Research BACKGROUND: With chronic ischemia after myocardial infarction, the resulting scar tissue result in electrical and structural remodeling vulnerable to an arrhythmogenic substrate. The cholinergic anti‐inflammatory pathway elicited by vagal nerve via α7 nicotinic acetylcholine receptors (α7‐nAChR) can modulate local and systemic inflammatory responses. Here, we aimed to clarify a novel mechanism for the antiarrhythmogenic properties of vagal nerve during the ischemic cardiomyopathy (ICM). METHODS AND RESULTS: Left anterior descending artery of adult male Sprague‐Dawley rats was ligated for 4 weeks to develop ICM. Western blot revealed that eliciting the cholinergic anti‐inflammatory pathway by nicotine treatment showed a significant reduction in the amounts of collagens, cytokines, and other inflammatory mediators in the left ventricular infarcted border zone via inhibited NF‐κB activation, whereas it increased the phosphorylated connexin 43. Vagotomy inhibited the anti‐inflammatory, anti‐fibrosis, and anti‐arrhythmogenic effect of nicotine administration. And immunohistochemistry confirmed that the nicotine administration‐induced increase of connexin 43 was located in intercellular junctions. Furthermore nicotine treatment suppressed NF‐κB activation in lipopolysaccharide‐stimulated RAW264.7 cells, and α‐bungarotoxin (an α7‐nAChR selective antagonist) partly inhibited the nicotine‐treatment effect. In addition, 4‐week nicotine administration slightly improved the cardiac function, increased cardiac parasympathetic tone, decreased the prolonged QTc, and decreased the arrhythmia score of programmed electric stimulation‐induced ventricular arrhythmia. CONCLUSIONS: Eliciting the cholinergic anti‐inflammatory pathway exerts anti‐arrhythmogenic effects against ICM‐induced ventricular arrhythmia accompanied by downregulation of cytokines, downgenerating of collagens, decrease in sympathetic/parasympathetic ratio, and prevention of the loss of phosphorylated connexin 43 during ICM. Our findings may suggest a promising therapy for the generation of ICM‐induced ventricular arrhythmia by eliciting the cholinergic anti‐inflammatory pathway. John Wiley and Sons Inc. 2017-09-19 /pmc/articles/PMC5634297/ /pubmed/28928157 http://dx.doi.org/10.1161/JAHA.117.006510 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Wu, Shu‐Jie
Li, Yue‐Chun
Shi, Zhe‐Wei
Lin, Zhong‐Hao
Rao, Zhi‐Heng
Tai, Si‐Chao
Chu, Mao‐Ping
Li, Lei
Lin, Jia‐Feng
Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart
title Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart
title_full Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart
title_fullStr Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart
title_full_unstemmed Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart
title_short Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart
title_sort alteration of cholinergic anti‐inflammatory pathway in rat with ischemic cardiomyopathy–modified electrophysiological function of heart
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634297/
https://www.ncbi.nlm.nih.gov/pubmed/28928157
http://dx.doi.org/10.1161/JAHA.117.006510
work_keys_str_mv AT wushujie alterationofcholinergicantiinflammatorypathwayinratwithischemiccardiomyopathymodifiedelectrophysiologicalfunctionofheart
AT liyuechun alterationofcholinergicantiinflammatorypathwayinratwithischemiccardiomyopathymodifiedelectrophysiologicalfunctionofheart
AT shizhewei alterationofcholinergicantiinflammatorypathwayinratwithischemiccardiomyopathymodifiedelectrophysiologicalfunctionofheart
AT linzhonghao alterationofcholinergicantiinflammatorypathwayinratwithischemiccardiomyopathymodifiedelectrophysiologicalfunctionofheart
AT raozhiheng alterationofcholinergicantiinflammatorypathwayinratwithischemiccardiomyopathymodifiedelectrophysiologicalfunctionofheart
AT taisichao alterationofcholinergicantiinflammatorypathwayinratwithischemiccardiomyopathymodifiedelectrophysiologicalfunctionofheart
AT chumaoping alterationofcholinergicantiinflammatorypathwayinratwithischemiccardiomyopathymodifiedelectrophysiologicalfunctionofheart
AT lilei alterationofcholinergicantiinflammatorypathwayinratwithischemiccardiomyopathymodifiedelectrophysiologicalfunctionofheart
AT linjiafeng alterationofcholinergicantiinflammatorypathwayinratwithischemiccardiomyopathymodifiedelectrophysiologicalfunctionofheart